Southeast Asset Advisors’s Alimera Sciences ALIM Stock Holding History

Southeast Asset Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-667	Closed	-$11K	–	110
2016 Q4	$11K	Hold	667	–	–	﹤0.01%	106
2016 Q3	$15K	Hold	667	–	–	0.01%	109
2016 Q2	$12K	Hold	667	–	–	﹤0.01%	106
2016 Q1	$18K	Hold	667	–	–	0.01%	100
2015 Q4	$24K	Hold	667	–	–	0.01%	94
2015 Q3	$22K	Hold	667	–	–	0.01%	84
2015 Q2	$46K	Hold	667	–	–	0.02%	91
2015 Q1	$50K	Hold	667	–	–	0.02%	85
2014 Q4	$55K	Sell	667 -166	-20%	-$13.5K	0.02%	93
2014 Q3	$68K	Hold	833	–	–	0.03%	93
2014 Q2	$75K	Hold	833	–	–	0.03%	97
2014 Q1	$99K	Sell	833 -167	-17%	-$16.2K	0.04%	98
2013 Q4	$71K	Hold	1,000	–	–	0.03%	101
2013 Q3	$56K	Hold	1,000	–	–	0.02%	100
2013 Q2	$73K	Buy	+1,000	New	+$57.7K	0.03%	89

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Southeast Asset Advisors's ALIM Position: Q1 2017 in Review

Southeast Asset Advisors sold out of Alimera Sciences (ALIM) in Q1 2017, closing a stake of 667 shares — an estimated $11K sold.

Southeast Asset Advisors first reported a position in ALIM in Q2 2013 and held it in 15 quarters. The position peaked at $99K in Q1 2014. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2017.

Southeast Asset Advisors reported no remaining Alimera Sciences position as of Q1 2017 after selling out during the quarter.
Southeast Asset Advisors sold 667 Alimera Sciences shares in Q1 2017, an estimated $11K.
Southeast Asset Advisors first reported a position in Alimera Sciences in Q2 2013 and held it in 15 quarters.
Southeast Asset Advisors's Alimera Sciences position peaked at $99K in Q1 2014.
39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2017.

Based on Southeast Asset Advisors's 13F filing for Q1 2017, filed 15 May 2017.